Blog
Solntrek registers the first patient in the next clinical examination of the second phase in order to develop the Aurazy wound gel
17
Mar
Mar
Solascure Ltd (Solascure), a biotechnology company developing new treatment to transform chronic wound healing, has today announced the start of a new clinical trial of phase II, Cleanvlu2. The entrance of the first patient from the study means a new clinical milestone in the development of a research product, Aurase Round Gel, to treat chronic […]
